FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982989919> ?p ?o ?g. }

• W1982989919 endingPage "400" @default.
• W1982989919 startingPage "392" @default.
• W1982989919 abstract "Introduction: Very-low–birth-weight (VLBW; birth weight, <1,500 g) infants receive preterm infant formulas and parenteral multivitamin preparations that provide more riboflavin (vitamin B2) than does human milk and more than that recommended by the American Society of Clinical Nutrition. VLBW infants who are not breast-fed may have plasma riboflavin concentrations up to 50 times higher than those in cord blood. The authors examined a vitamin regimen designed to reduce daily riboflavin intake, with the hypothesis that this new regimen would result in lower plasma riboflavin concentrations while maintaining lipid-soluble vitamin levels. Methods: Preterm infants with birth weight ≤1,000 g received either standard preterm infant nutrition providing 0.42 to 0.75 mg riboflavin/kg/day (standard group), or a modified regimen providing 0.19 to 0.35 mg/kg/day (modified group). The modified group parenteral vitamin infusion was premixed in Intralipid®. Enteral feedings were selected to meet daily riboflavin administration guidelines. Plasma riboflavin, vitamin A, and vitamin E concentrations were measured weekly by high-performance liquid chromatography. Data were analyzed with the independent t test, χ2, and analysis of variance. Results: The 36 infants (17 standard group, 19 modified group) had birth weight and gestational age of 779 ± 29 g and 25.5 ± 0.3 weeks (mean ± SEM) with no differences between groups. Modified group infants received 38% less riboflavin (0.281 ± 0.009 mg/kg/day), 35% more vitamin A (318.3 ± 11.4 μg/kg/day), and 14% more vitamin E (3.17 ± 0.14 mg/kg/day) than standard group infants. Plasma riboflavin rose from baseline in both groups but was 37% lower in the modified group during the first postnatal month (133.3 ± 9.9 ng/mL). Riboflavin intake and plasma riboflavin concentrations were directly correlated. Plasma vitamin A (0.222 ± 0.022 μg/mL) and vitamin E (22.26 ± 1.61 /mL) concentrations were greater in the modified group. Conclusions: The modified vitamin regimen resulted in reduced riboflavin intake and plasma riboflavin concentration, suggesting plasma riboflavin concentration is partially dose dependent during the first postnatal month in VLBW infants. Modified group plasma vitamin A and vitamin E concentrations were greater during the first month, possibly because the vitamins were premixed with parenteral lipid emulsion. Because of the complexity of this protocol, the authors suggest that a parenteral multivitamin product designed for VLBW infants which uses weight-based dosing should be developed." @default.
• W1982989919 created "2016-06-24" @default.
• W1982989919 creator A5002068592 @default.
• W1982989919 creator A5010632583 @default.
• W1982989919 creator A5038991891 @default.
• W1982989919 date "2004-04-01" @default.
• W1982989919 modified "2023-09-30" @default.
• W1982989919 title "A Modified Vitamin Regimen for Vitamin B2, A, and E Administration in Very-Low–Birth-Weight Infants" @default.
• W1982989919 cites W120336469 @default.
• W1982989919 cites W1793531678 @default.
• W1982989919 cites W1963010240 @default.
• W1982989919 cites W1979642475 @default.
• W1982989919 cites W1984801521 @default.
• W1982989919 cites W1984970385 @default.
• W1982989919 cites W1986622778 @default.
• W1982989919 cites W1987037481 @default.
• W1982989919 cites W1993974926 @default.
• W1982989919 cites W2008999861 @default.
• W1982989919 cites W2013691198 @default.
• W1982989919 cites W2018458842 @default.
• W1982989919 cites W2020195438 @default.
• W1982989919 cites W2020429731 @default.
• W1982989919 cites W2026607086 @default.
• W1982989919 cites W2028723042 @default.
• W1982989919 cites W2033624890 @default.
• W1982989919 cites W2036743010 @default.
• W1982989919 cites W2042001548 @default.
• W1982989919 cites W2042283649 @default.
• W1982989919 cites W2044832082 @default.
• W1982989919 cites W2044917584 @default.
• W1982989919 cites W2048310792 @default.
• W1982989919 cites W2053489365 @default.
• W1982989919 cites W2073352545 @default.
• W1982989919 cites W2077614430 @default.
• W1982989919 cites W2092092717 @default.
• W1982989919 cites W2093705830 @default.
• W1982989919 cites W2097067050 @default.
• W1982989919 cites W2121987917 @default.
• W1982989919 cites W2142697870 @default.
• W1982989919 cites W2186884130 @default.
• W1982989919 cites W2318788208 @default.
• W1982989919 cites W2323705091 @default.
• W1982989919 cites W2335167117 @default.
• W1982989919 cites W2394789833 @default.
• W1982989919 cites W37260293 @default.
• W1982989919 cites W4245464962 @default.
• W1982989919 cites W4323526726 @default.
• W1982989919 doi "https://doi.org/10.1097/00005176-200404000-00006" @default.
• W1982989919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15085017" @default.
• W1982989919 hasPublicationYear "2004" @default.
• W1982989919 type Work @default.
• W1982989919 sameAs 1982989919 @default.
• W1982989919 citedByCount "11" @default.
• W1982989919 countsByYear W19829899192014 @default.
• W1982989919 countsByYear W19829899192015 @default.
• W1982989919 countsByYear W19829899192018 @default.
• W1982989919 countsByYear W19829899192021 @default.
• W1982989919 crossrefType "journal-article" @default.
• W1982989919 hasAuthorship W1982989919A5002068592 @default.
• W1982989919 hasAuthorship W1982989919A5010632583 @default.
• W1982989919 hasAuthorship W1982989919A5038991891 @default.
• W1982989919 hasBestOaLocation W19829899191 @default.
• W1982989919 hasConcept C126322002 @default.
• W1982989919 hasConcept C185592680 @default.
• W1982989919 hasConcept C187212893 @default.
• W1982989919 hasConcept C2775871700 @default.
• W1982989919 hasConcept C2776155809 @default.
• W1982989919 hasConcept C2776551950 @default.
• W1982989919 hasConcept C2776940978 @default.
• W1982989919 hasConcept C2778376644 @default.
• W1982989919 hasConcept C2779083892 @default.
• W1982989919 hasConcept C2779150110 @default.
• W1982989919 hasConcept C2779234561 @default.
• W1982989919 hasConcept C2781413609 @default.
• W1982989919 hasConcept C42407357 @default.
• W1982989919 hasConcept C44315111 @default.
• W1982989919 hasConcept C54355233 @default.
• W1982989919 hasConcept C55493867 @default.
• W1982989919 hasConcept C66322754 @default.
• W1982989919 hasConcept C71924100 @default.
• W1982989919 hasConcept C78722104 @default.
• W1982989919 hasConcept C86803240 @default.
• W1982989919 hasConcept C90924648 @default.
• W1982989919 hasConceptScore W1982989919C126322002 @default.
• W1982989919 hasConceptScore W1982989919C185592680 @default.
• W1982989919 hasConceptScore W1982989919C187212893 @default.
• W1982989919 hasConceptScore W1982989919C2775871700 @default.
• W1982989919 hasConceptScore W1982989919C2776155809 @default.
• W1982989919 hasConceptScore W1982989919C2776551950 @default.
• W1982989919 hasConceptScore W1982989919C2776940978 @default.
• W1982989919 hasConceptScore W1982989919C2778376644 @default.
• W1982989919 hasConceptScore W1982989919C2779083892 @default.
• W1982989919 hasConceptScore W1982989919C2779150110 @default.
• W1982989919 hasConceptScore W1982989919C2779234561 @default.
• W1982989919 hasConceptScore W1982989919C2781413609 @default.
• W1982989919 hasConceptScore W1982989919C42407357 @default.
• W1982989919 hasConceptScore W1982989919C44315111 @default.
• W1982989919 hasConceptScore W1982989919C54355233 @default.

• next